Cancer incidence is rising across the globe. Every year, one in two Americans are diagnosed, early onset cancer rates are projected to increase 31% by 2030, and cancer continues to hold steady as employers' top expense with treatment costs skyrocketing, rising at 8.5% year over year.
Employers have traditionally focused more on the aftermath of a diagnosis, but to effectively control the impact of cancer, employers need to shift their strategy. Key to this approach is combining early and rapid detection and diagnosis of cancer with effective care and support of employees undergoing treatment as well as those in remission.
Hear from industry experts and learn:
- How to overcome challenges of early detection among employees, including lack of awareness, accessibility issues, and fear of diagnosis
- How delays in the cancer care continuum—from initial suspicion to confirmed diagnosis—impact patient outcomes and employer healthcare costs
- How to better connect early detection with optimized treatment and effective employee support, while reducing costs to your organization
